Millipore Home

• Home
• Products
• Services
• Learning Center
• Tech Library
• Support
• Company

Product Reference

The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation.

Author	J F Martini, C Piot, L M Humeau, I Struman, J A Martial, R I Weiner, J F Martini, C Piot, L M Humeau, I Struman, J A Martial, R I Weiner
Citation Information	Molecular endocrinology (Baltimore, Md.), 14:1536-49 (2000)
Keywords	Antibodies, Monoclonal, Apoptosis, Caspases, Cell Division, Cell Line, DNA, DNA Fragmentation, Drug Contamination, Endothelium, Vascular, Endotoxins, Enzyme Activation, Escherichia coli, Female, Hot Temperature, Humans, Molecular Weight, Neovascularization, Physiologic, Peptide Fragments, Prolactin, Protein Denaturation, Proto-Oncogene Proteins c-bcl-2, Receptors, Prolactin, Receptors, Somatotropin, Recombinant Proteins, Trypsin
Applications	Immunoblotting (Western)
Related Products	PP54
Pub Med ID	11043570

We asked whether the antiangiogenic action of 16K human PRL (hPRL), in addition to blocking mitogen-induced vascular endothelial cell proliferation, involved activation of programmed cell death. Treatment with recombinant 16K hPRL increased DNA fragmentation in cultured bovine brain capillary endothelial (BBE) and human umbilical vein endothelial (HUVE) cells in a time- and dose-dependent fashion, independent of the serum concentration. The activation of apoptosis by 16K hPRL was specific for endothelial cells, and the activity of the peptide could be inhibited by heat denaturation, trypsin digestion, and immunoneutralization, but not by treatment with the endotoxin blocker, polymyxin-B. 16K hPRL-induced apoptosis was correlated with the rapid activation of caspases 1 and 3 and was blocked by pharmacological inhibition of caspase activity. Caspase activation was followed by inactivation of two caspase substrates, poly(ADP-ribose) polymerase (PARP) and the inhibitor of caspase-activated deoxyribonuclease (DNase) (ICAD). Furthermore, 16K hPRL increased the conversion of Bcl-X to its proapoptotic form, suggesting that the Bcl-2 protein family may also be involved in 16K hPRL-induced apoptosis. These findings support the hypothesis that the antiangiogenic action of 16K hPRL includes the activation of programmed cell death of vascular endothelial cells.